Status:
TERMINATED
Visual Telerehabilitation in AMD Patients
Lead Sponsor:
Michael Reber
Conditions:
Macular Degeneration
Eligibility:
All Genders
Phase:
NA
Brief Summary
Following the degeneration of the macula and the loss of central vision, the patients naturally relocate the fixation point for high visual acuity peripherally, in an eccentric and healthy part of the...
Eligibility Criteria
Inclusion
- Dry-AMD.
- BCVA \> 20/160.
- Ability to follow the visual and auditory stimuli and training instructions.
- Auditory test positive at 50Hz 25-60dBHL.
- Home Wi-Fi access.
Exclusion
- Wet AMD.
- Both eyes with media opacity that impairs microperimetry testing.
- Inability to perform during testing and training.
- Psychoactive drugs consumption.
- 3 consecutive VRISE scores \< 25 at inclusion.
- History of vertigo or dizziness
- Prior vision rehabilitation interventions.
Key Trial Info
Start Date :
September 15 2021
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
October 6 2023
Estimated Enrollment :
16 Patients enrolled
Trial Details
Trial ID
NCT04685824
Start Date
September 15 2021
End Date
October 6 2023
Last Update
November 30 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Krembil Research Institute/Toronto Western Hospital
Toronto, Ontario, Canada, M5T 0S8